EC Number |
Inhibitors |
Structure |
---|
2.7.11.11 | (Rp)-adenosine 3',5'-cyclic monophosphorothionate triethyl ammonium salt |
inhibitor of PKA |
|
2.7.11.11 | (Rp)-adenosine 3',5'-cyclic monophosphothioate |
i.e. (Rp)-cAMPS, analogue of cAMP, competitive inhibition of PKA activation by cAMP, binding site structure |
|
2.7.11.11 | (Rp)-adenosine-3',5'-cyclic monophosphorothioate |
inhibits PKA |
|
2.7.11.11 | (Rp)-adenosine-3',5'-cyclic monophosphorothioate |
PKA inhibitor |
|
2.7.11.11 | (Sp)-adenosine 3',5'-cyclic monophosphothioate |
i.e. (Sp)-cAMPS, analogue of cAMP, competitive inhibition of PKA activation by cAMP, binding site structure |
|
2.7.11.11 | 7-hydroxystaurosporine |
specific protein kinase inhibitor |
|
2.7.11.11 | Acetylsalicylic acid |
a non-steroidal anti-inflammatory drug, decreases adrenaline- or dibutyryl cAMP-stimulated glycerol release in isolated adipocytes |
|
2.7.11.11 | AdcAhxArg6 |
i.e. adenosine 5'-carboxylic acid-6-aminohexanoic acid-L-arginine, peptide-nucleoside conjugate inhibitor, inhibition of the catalytic subunit, binding mechanism |
|
2.7.11.11 | adenosine 3',5'-cyclic phosphorothioate |
- |
|
2.7.11.11 | adenosine 5'-(beta,gamma-Imino)triphosphate |
binding structure at the ATP binding site |
|